Abedalthagafi M, Bi WL, Aizer AA et al (2016) Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol 18:649–655

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bi WL, Greenwald NF, Abedalthagafi M et al. (2017) Genomic landscape of high-grade meningiomas. NPJ Genom Med 2

Biczok A, Thorsteinsdottir J, Karschnia P et al (2023) Mutational signature of extracranial meningioma metastases and their respective primary tumors. Acta Neuropathol Commun 11:12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clark VE, Erson-Omay EZ, Serin A et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077–1080

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui J, Zou X, Han Y et al (2024) Benign extracranial meningioma with pulmonary metastasis: a case report and review of literature. J Med Case Rep 18:461

Article  PubMed  PubMed Central  Google Scholar 

Felix S, Arie P, Andreas D et al. (2021) Meningioma. In: WHO Classification of Tumours Editorial Board. WHO classification of tumours series, 5th edn, vol. 6. Central nervous system tumours. International Agency for Research on Cancer, Lyon, 2021. Available from: https://tumourclassification.iarc.who.int/chapters/45.

Gendreau JL, Chow KKH, Sussman ES et al (2017) DNA methylation analysis for the treatment of meningiomas. J Vis Surg 3:178

Article  PubMed  PubMed Central  Google Scholar 

Gupta M, Samiappan SPS, Alanya H et al (2025) Somatic SMARCB1 mutation in spinal meningioma represents branched evolution in a patient with multiple sporadic meningiomas. Neuro-Oncol Adv 7:vdaf067

Article  Google Scholar 

Hu ZI, Miettinen M, Quezado M et al (2022) Meningiomas in patients with malignant pleural mesothelioma harboring germline BAP1 mutations. J Thorac Oncol 17:461–466

Article  CAS  PubMed  Google Scholar 

Landry AP, Wang JZ, Nassiri F et al (2023) BAP1-deficient meningioma presenting with trabecular architecture and cytokeratin expression: a report of two cases and review of the literature. J Clin Pathol 76:315–319

Article  PubMed  Google Scholar 

Liu J, Yan Z, Lin F et al (2025) A case of rhabdoid meningioma originating from the optic nerve. Neuropathology 45:e13028

Article  PubMed  Google Scholar 

Manookian R, Cotter J, Ji J et al (2024) Rare within the rare: A case of young-onset meningioma revealing the diagnosis of BAP1-tumor predisposition syndrome. Genet Med Open 2(Suppl 1):P099

Google Scholar 

Masclef L, Ahmed O, Estavoyer B et al (2021) Roles and mechanisms of BAP1 deubiquitinase in tumor suppression. Cell Death Differ 28:606–625

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pandithan D, Klebe S, McKavanagh G et al (2022) BAP1 Tumour predisposition syndrome due to Whole BAP1 Gene Deletion. Case Rep Genet 2022:5503505

PubMed  PubMed Central  Google Scholar 

Prasad RN, Gardner UG, Yaney A et al (2021) Germline BAP1 mutation in a family with multi-generational meningioma with rhabdoid features: a case series and literature review. Front Oncol 11:721712

Article  PubMed  PubMed Central  Google Scholar 

Price M, Ballard C, Benedetti J et al (2024) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2017–2021. Neuro Oncol 26:vi1–vi85

Article  PubMed  Google Scholar 

Rai K, Pilarski R, Cebulla CM et al (2016) Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases. Clin Genet 89:285–294

Article  CAS  PubMed  Google Scholar 

Ravanpay AC, Barkley A, White-Dzuro GA et al (2018) Giant pediatric rhabdoid meningioma associated with a germline BAP1 pathogenic variation: a rare clinical case. World Neurosurg 119:402–415

Article  PubMed  Google Scholar 

Shankar GM, Abedalthagafi M, Vaubel RA et al (2017) Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncol 19:535–545

Article  CAS  PubMed  Google Scholar 

Shankar GM, Santagata S (2017) BAP1 mutations in high-grade meningioma: implications for patient care. Neuro Oncol 19:1447–1456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sievers P, Arora S, Hielscher T et al (2025) Molecular signatures define BAP1-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genes. Neuro Oncol. https://doi.org/10.1093/neuonc/noaf105

Article  PubMed  PubMed Central  Google Scholar 

Tosefsky K, Martin KC, Rebchuk AD et al (2024) Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B status. Neurooncol Adv 6:vdae002

PubMed  PubMed Central  Google Scholar 

Wang JZ, Landry AP, Raleigh DR et al (2024) Meningioma: international consortium on meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients. Neuro Oncol 26:1742–1780

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu A, Ring AC, Ziskin J et al (2024) Primary BAP1-absent atypical meningioma arising from median nerve within infraclavicular brachial plexus: illustrative case. J Neurosurg Case Lessons. https://doi.org/10.3171/CASE24226

Article  PubMed  PubMed Central  Google Scholar